; and (iii) a set of standards for prostate cancer screening, developed in coordination with the United States Preventive Services Task Force, to ensure that any tools for screening, detection, and diagnosis developed in accordance with the plan under clause (ii) will meet the requirements of the Task Force for recommendation as a proven preventive or diagnostic service. (E) Termination The advisory council shall terminate on December 31, 2024. (3) Funding The Secretary may make available $1,000,000 from amounts appropriated to the National Institutes of Health for each of fiscal years 2021 through 2025 to carry out this subsection. (c) Coordination and intensification of prostate cancer research (1) In general The Director of the National Institutes of Health, in consultation with the Secretary of Defense, shall coordinate and intensify research in accordance with the plan, with particular attention provided to leveraging existing research to develop and validate a test or tests, such as biomarkers or imaging, to detect and accurately diagnose prostate cancer in order to improve quality of life for millions of Americans, and decrease health care system costs. (2) Funding The Secretary may make available $30,000,000 from amounts appropriated to the National Institutes of Health for each of fiscal years 2022 through 2026 to carry out this subsection. (d) Public awareness and education campaign (1) National campaign The Secretary, in coordination with the Director of the National Institutes of Health and the Director of the Centers for Disease Control and Prevention, shall carry out a national campaign to increase the awareness and knowledge of prostate cancer. (2) Requirements The national campaign conducted under paragraph (1) shall include— (A) roles for the National Cancer Institute, the National Institute on Minority Health and Health Disparities, the Office on Minority Health of the Department of Health and Human Services, and the Office of Minority Health of the Centers for Disease Control and Prevention